(HealthDay)—The risk for mortality is increased in association with infection with a new variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) designated a variant of […]
Londoners receiving the Oxford/AstraZeneca vaccine on Tuesday dismissed concerns about its potential risks, after several countries suspended its use due to fears about blood clots.